These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 19998251

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Chapter VI: Follow-up after revascularisation.
    Dick F, Ricco JB, Davies AH, Cao P, Setacci C, de Donato G, Becker F, Robert-Ebadi H, Eckstein HH, De Rango P, Diehm N, Schmidli J, Teraa M, Moll FL, Lepäntalo M, Apelqvist J.
    Eur J Vasc Endovasc Surg; 2011 Dec; 42 Suppl 2():S75-90. PubMed ID: 22172475
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antithrombotic therapy in peripheral artery disease--antiplatelet therapy, anticoagulants, both or none.
    Tangelder MJ, van Hattum ES.
    Thromb Haemost; 2010 Aug; 104(2):196-9. PubMed ID: 20508897
    [No Abstract] [Full Text] [Related]

  • 7. Three-year cardiovascular events and disease progress in patients with peripheral arterial disease: results from the Japan Medication Therapy for Peripheral Arterial Disease (J-METHOD).
    Shigematsu H, Nishibe T, Obitsu Y, Matsuzaki K, Ishida A, Miyata T, Shindo S, Hida K, Ohta T, Ando M, Kawasaki T, Yasugi T, Matsumoto T.
    Int Angiol; 2010 Apr; 29(2 Suppl):2-13. PubMed ID: 20357743
    [Abstract] [Full Text] [Related]

  • 8. Antithrombotic therapy in peripheral arterial disease.
    Lipsitz EC, Kim S.
    Clin Geriatr Med; 2006 Feb; 22(1):183-98, x. PubMed ID: 16377474
    [Abstract] [Full Text] [Related]

  • 9. Regarding "Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons".
    Paraskevas KI.
    J Vasc Surg; 2008 Sep; 48(3):776-7; author reply 777. PubMed ID: 18727983
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Anti-platelet therapy: is it all over in peripheral artery disease?
    Jaipersad AS, Silverman SH, Lip GY.
    Thromb Haemost; 2010 Apr; 103(4):689-91. PubMed ID: 20174749
    [No Abstract] [Full Text] [Related]

  • 13. Duplex ultrasound surveillance can be worthwhile after arterial intervention.
    Bandyk DF, Chauvapun JP.
    Perspect Vasc Surg Endovasc Ther; 2007 Dec; 19(4):354-9; discussion 360-1. PubMed ID: 18287140
    [Abstract] [Full Text] [Related]

  • 14. [Risk factor control in peripheral arterial disease can be improved. Registry study of secondary prophylactic drug therapy].
    Alhadad A, Wiktorsson C, Lindblad B, Gottsäter A.
    Lakartidningen; 2007 Dec; 107(39):2322-5. PubMed ID: 20973248
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Is there a role for oral anticoagulant therapy in patients with peripheral arterial disease?
    Cosmi B, Palareti G.
    Curr Drug Targets Cardiovasc Haematol Disord; 2004 Sep; 4(3):269-73. PubMed ID: 15379620
    [Abstract] [Full Text] [Related]

  • 18. Oral anticoagulant and antiplatelet therapy and peripheral arterial disease.
    Warfarin Antiplatelet Vascular Evaluation Trial InvestigatorsMcMaster University, Hamilton, ON, Canada. anands@mcmaster.ca, Anand S, Yusuf S, Xie C, Pogue J, Eikelboom J, Budaj A, Sussex B, Liu L, Guzman R, Cina C, Crowell R, Keltai M, Gosselin G.
    N Engl J Med; 2007 Jul 19; 357(3):217-27. PubMed ID: 17634457
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.